Stereotaxis Launches Advanced Robotic Cardiology Program in Hungary

Stereotaxis has announced the launch of the first advanced robotic cardiology program in Hungary at the University of Szeged in Szeged, Hungary.

The Cardiology Center (Szent-Györgyi Albert Clinical Center) at the University of Szeged is the first hospital in Hungary to establish a heart rhythm program featuring the Genesis Robotic Magnetic Navigation System. Genesis is designed to advance the standard of care for patients with complex cardiac arrhythmias with robotic precision and safety. Physicians at the hospital have successfully treated their first patients with a broad range of arrhythmias using the system’s advanced capabilities. The adoption of Genesis is part of a broader hospital-wide initiative to elevate clinical excellence and expand access to the most impactful innovations in medicine.

“We are delighted to be bringing advanced robotic technology to patients in Hungary and look forward to improving the quality of catheter ablation therapy available for the full spectrum of arrhythmia patients,” said Prof. Tamás Szili-Török, Vice Dean of Science and Innovation and Director of Cardiology Center at the University of Szeged. “As an advanced user of robotics, I have seen firsthand its clinical value. We expect to treat a broad spectrum of arrhythmia patients with Genesis, to become a central training institute, and to contribute to the advancement of robotics in cardiology with pioneering research and innovation. This is a significant milestone for patients in Hungary, and we are pleased to be pioneering this.”

Robotic Magnetic Navigation introduces the benefits of robotic precision and safety to cardiac ablation, a common minimally invasive procedure to treat arrhythmias. Tens of millions of individuals worldwide suffer from arrhythmias – abnormal heart rhythms that result when the heart beats too quickly, too slowly, or with an irregular pattern. When left untreated, arrhythmias may significantly increase the risk of stroke, heart failure, and sudden cardiac arrest.

“We’re honored to partner with the University of Szeged and have the opportunity to work again with Dr. Szili-Torok, an original founder of the Society of Cardiac Robotic Navigation,” said David Fischel, Chairman and CEO of Stereotaxis. “We look forward to supporting growth of their leading robotic center and working together to advance innovation, research, and patient care.”

Source: Stereotaxis

The post Stereotaxis Launches Advanced Robotic Cardiology Program in Hungary appeared first on Surgical Robotics Technology.